Supports breast cancer research with high potential for breakthroughs through clinical trials. Requires addressing FY26 BCRP challenges and inclusion of breast cancer consumer advocates. Allows single or dual PI teams with specific application submission requirements. Focuses on research leading to clinical application at Breakthrough Award Level 4.
Open to any type of entity, with no specific restrictions stated. Research teams must include two or more breast cancer consumer advocates. Single or dual Principal Investigator options are allowed.
